POST Online Media Lite Edition



 

CEO Chris Yates to leave Immunodiagnostic Systems

Staff writer |
London, United Kingdom - December 8, 2014, London, United Kingdom - Immunodiagnostic Systems Holdings (IDS) announces that CFO Chris Yates gave notice of his intention to leave at the end of his 12 month notice period, or as may be agreed otherwise.

Article continues below






Mr. Yates joined IDS from private equity backed Nexus Vehicle Holdings Limited, where he has acted as Group Finance Director since January 2009. During his time at Nexus, as well as holding overall responsibility for finance and human resources, he oversaw the acquisition of Adapted Vehicle Hire Limited in May 2010.

From 2005 to 2007, Mr. Yates held the position of Group Finance Director at Cozart plc, allowing him to gain significant experience in the medical diagnostics industry. During his time at Cozart, he led the acquisitions of four European companies: Spinreact SA (Spain), HL Scandinavia (Sweden), Nemesis Scientific Limited (UK) and Medib Skandinavien AB (Sweden) creating a pan-European medical diagnostics group.

 LATEST MOVES FROM United Kingdom 

Rolls-Royce appoints Panos Kakoullis as CFO
British Airways chairman and CEO Alex Cruz replaced
Ascential appoints Paul Harrison as COO
Petropavlovsk appoints Maksim Meshcheriakov as interim CEO
Helios Towers appoints Sally Ashford as director

What to read next

Jupiter Fund Management appoints Roger Yates as director
Fidelity European Values appoints Paul Yates as director
Immunodiagnostic Systems appoints Chris Yates as group finance director